← Back to Search

Other

Alcohol for Alcoholism

N/A
Waitlist Available
Led By Mark Fillmore, Ph.D.
Research Sponsored by Mark Fillmore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial will study how alcohol affects hormones and the brain differently in men and women who drink heavily.

Eligible Conditions
  • Alcoholism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Brain Activation During Response Inhibition (BARI)
Secondary outcome measures
Change in Biphasic Alcohol Effects Score
Change in Drug Effects Questionnaire Score
Change in Estradiol Levels
+2 more

Side effects data

From 2017 Phase 2 trial • 17 Patients • NCT01779024
59%
Increased Appetite
41%
Somnolence
35%
Euphoric mood
29%
Fatigue
12%
Memory impairment
12%
Hyperhidrosis
12%
Dizziness
12%
Nausea
6%
Feeling hot
6%
Flushing
6%
Headache
6%
Decreased appetite
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ghrelin
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Group I: MalesExperimental Treatment1 Intervention
Participants in this group will be adult male heavy drinkers.
Group II: FemalesExperimental Treatment1 Intervention
Participants in this group will be adult female heavy drinkers. Data will be segregated by menstrual cycle phase - the late follicular or mid-luteal phase.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Alcohol
2008
Completed Phase 3
~2000

Find a Location

Who is running the clinical trial?

Mark FillmoreLead Sponsor
2 Previous Clinical Trials
220 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
799 Previous Clinical Trials
1,362,489 Total Patients Enrolled
422 Trials studying Alcoholism
985,186 Patients Enrolled for Alcoholism
Jessica WeaferLead Sponsor
4 Previous Clinical Trials
521 Total Patients Enrolled
4 Trials studying Alcoholism
521 Patients Enrolled for Alcoholism

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers have enrolled in this research project?

"Affirmative. The information found on clinicaltrials.gov affirms that the trial is actively recruiting, having first been posted on November 1st 2019 and last updated on May 17th 2022. An estimated 60 patients need to be procured from a solitary medical facility for this experiment."

Answered by AI

Is this study recruiting new participants?

"According to the latest updates on clinicaltrials.gov, this medical trial is actively seeking participants. The project's initial post date was November 1st 2019 and it was recently revised on May 17th 2022."

Answered by AI

Which type of patient is most suitable for enrollment in this clinical study?

"Individuals with a history of alcohol abuse that are between 21 and 29 years old have the opportunity to join this clinical trial. The research team is expecting around 60 people to enroll in total."

Answered by AI

For what purposes is Alcohol typically prescribed?

"Obstructive hypertrophic cardiomyopathy is a condition that can be handled through the administration of alcohol. Other illnesses and conditions which may benefit from this treatment include communicable diseases, ethylene glycol exposure and skin disinfection therapy."

Answered by AI

Does the protocol for this trial stipulate a maximum age limit?

"This trial is available to those aged 21-29; by contrast there are 26 clinical studies open to minors and 212 trials that cater to elderly individuals."

Answered by AI
~4 spots leftby Apr 2025